4.8 Article

Nitric Oxide Releasing Coronary Stent: A New Approach Using Layer-by-Layer Coating and Liposomal Encapsulation

Journal

SMALL
Volume 12, Issue 43, Pages 6012-6023

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/smll.201600337

Keywords

-

Funding

  1. Cell Regeneration Program [NRF-2012M3A9C6049717]
  2. Next Generation Medical Device Platform Program [NRF-2015M3A9E2028580]
  3. Pioneer Research Center Program through National Research Foundation of Korea - Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea [2014M3C1A3056052, 10062079]
  4. Korea Evaluation Institute of Industrial Technology (KEIT) of Ministry of Trade, Industry and Energy, Republic of Korea
  5. National Research Foundation of Korea [142S-4-2-1109, 2014M3A9D3033887, 2014M3C1A3056052, 2012M3A9C6049717] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

The sustained or controlled release of nitric oxide (NO) can be the most promising approach for the suppression or prevention of restenosis and thrombosis caused by stent implantation. The aim of this study is to investigate the feasibility in the potential use of layer-by-layer (LBL) coating with a NO donor-containing liposomes to control the release rate of NO from a metallic stent. Microscopic observation and surface characterizations of LBL-modified stents demonstrate successful LBL coating with liposomes on a stent. Release profiles of NO show that the release rate is sustained up to 5 d. In vitro cell study demonstrates that NO release significantly enhances endothelial cell proliferation, whereas it markedly inhibits smooth muscle cell proliferation. Finally, in vivo study conducted with a porcine coronary injury model proves the therapeutic efficacy of the NO-releasing stents coated by liposomal LBL technique, supported by improved results in luminal healing, inflammation, and neointimal thickening except thrombo-resistant effect. As a result, all these results demonstrate that highly optimized release rate and therapeutic dose of NO can be achieved by LBL coating and liposomal encapsulation, followed by significantly efficacious outcome in vivo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available